Trial Profile
An Open-Label, Multicenter Study To Evaluate The Efficacy, Safety And Tolerability Of Celecoxib (YM177) In Patients With Posttraumatic Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Nov 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 21 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.